Annals of the New York Academy of Sciences · 2006 · 39 citations · 11 references
PharmacyPharmaceuticsPharmacologyDrug DeliveryGene DeliveryNanoparticle Drug DeliveryCancer NanomedicineNanocarriers For TherapeuticsNanomedicineNanoparticle DesignNucleic Acid DeliveryOligonucleotide DeliveryAnimal Disease ModelsAnimal Models Of DiseaseAntisense Oligonucleotide SilencingAntisense RnasBone Tumor MetastasisGene Delivery NanoparticlesOligonucleotide StabilityOligonucleotide Therapeutics
The goal of our research is to provide a practical platform for drug delivery in oligonucleotide therapy. We report here the efficacy of an atelocollagen-mediated oligonucleotide delivery system applied to systemic siRNA and antisense oligonucleotide treatments in animal disease models. Atelocollagen and oligonucleotides formed a complex of nanosized particles, which was highly stable against nucleases. The complex allowed oligonucleotides to be delivered efficiently into several organs and tissues via intravenous administration. In a tumor metastasis model, the complex successfully delivered siRNA to metastasized tumors in bone tissue and inhibited their growth. We also demonstrated that a single intravenous treatment of the antisense oligodeoxynucleotide complex suppressed ear dermatitis in a contact hypersensitivity model. These results indicate the strong potential of the atelocollagen-mediated drug delivery system for practical therapeutic technology.
11
A Small Interfering RNA Targeting Vascular Endothelial Growth Factor as Cancer Therapeutics
Yoshifumi Takei, Kenji Kadomatsu, Yukio Yuzawa et al. · Cancer Research · 2004 · 381 citations · Full text
Medicine, Cancer Biology, Oncology +17